Literature DB >> 24434637

Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.

Aijun Sun1, Yong Cheng2, Yingmei Zhang3, Qian Zhang4, Shijun Wang5, Shan Tian6, Yunzeng Zou5, Kai Hu7, Jun Ren8, Junbo Ge5.   

Abstract

Mitochondrial aldehyde dehydrogenase (ALDH2) protects against cardiac injury via reducing production of 4-hydroxynonenal (4-HNE) and ROS. This study was designed to examine the impact of ALDH2 on doxorubicin (DOX)-induced cardiomyopathy and mechanisms involved with a focus on autophagy. 4-HNE and autophagic markers were detected by Western blotting in ventricular tissues from normal donors and patients with idiopathic dilated cardiomyopathy. Cardiac function, 4-HNE and levels of autophagic markers were detected in WT, ALDH2 knockout or ALDH2 transfected mice treated with or without DOX. Autophagy regulatory signaling including PI-3K, AMPK and Akt was examined in DOX-treated cardiomyocytes incubated with or without ALDH2 activator Alda-1. DOX-induced myocardial dysfunction, upregulation of 4-HNE and autophagic proteins were further aggravated in ALDH2 knockout mice while they were ameliorated in ALDH2 transfected mice. DOX downregulated Class I and upregulated Class III PI3-kinase, the effect of which was augmented by ALDH2 deletion. Accumulation of 4-HNE and autophagic protein markers in DOX-induced cardiomyocytes was significantly reduced by Alda-1. DOX depressed phosphorylated Akt but not AMPK, the effect was augmented by ALDH2 knockout. The autophagy inhibitor 3-MA attenuated, whereas autophagy inducer rapamycin mimicked DOX-induced cardiomyocyte contractile defects. In addition, rapamycin effectively mitigated Alda-1-offered protective action against DOX-induced cardiomyocyte dysfunction. Our data further revealed downregulated ALDH2 and upregulated autophagy levels in the hearts from patients with dilated cardiomyopathy. Taken together, our findings suggest that inhibition of 4-HNE and autophagy may be a plausible mechanism underscoring ALDH2-offered protection against DOX-induced cardiac defect. This article is part of a Special Issue entitled "Protein Quality Control, the Ubiquitin Proteasome System, and Autophagy".
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  4-HNE; ALDH2; Autophagy; Dilated cardiomyopathy; Doxorubicin

Mesh:

Substances:

Year:  2014        PMID: 24434637     DOI: 10.1016/j.yjmcc.2014.01.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  36 in total

1.  Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice.

Authors:  Shahid P Baba; Deqing Zhang; Mahavir Singh; Sujith Dassanayaka; Zhengzhi Xie; Ganapathy Jagatheesan; Jingjing Zhao; Virginia K Schmidtke; Kenneth R Brittian; Michael L Merchant; Daniel J Conklin; Steven P Jones; Aruni Bhatnagar
Journal:  J Mol Cell Cardiol       Date:  2018-04-05       Impact factor: 5.000

2.  Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.

Authors:  Cong Wang; Fan Fan; Quan Cao; Cheng Shen; Hong Zhu; Peng Wang; Xiaona Zhao; Xiaolei Sun; Zhen Dong; Xin Ma; Xiangwei Liu; Shasha Han; Chaoneng Wu; Yunzeng Zou; Kai Hu; Junbo Ge; Aijun Sun
Journal:  J Mol Med (Berl)       Date:  2016-08-03       Impact factor: 4.599

Review 3.  Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay.

Authors:  Leonardo Schirone; Luca D'Ambrosio; Maurizio Forte; Riccardo Genovese; Sonia Schiavon; Giulia Spinosa; Giuliano Iacovone; Valentina Valenti; Giacomo Frati; Sebastiano Sciarretta
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

4.  ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.

Authors:  Yawen Gao; Yan Xu; Songwen Hua; Shenghua Zhou; Kangkai Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Carnosine protects cardiac myocytes against lipid peroxidation products.

Authors:  Jingjing Zhao; Dheeraj Kumar Posa; Vijay Kumar; David Hoetker; Amit Kumar; Smirthy Ganesan; Daniel W Riggs; Aruni Bhatnagar; Michael F Wempe; Shahid P Baba
Journal:  Amino Acids       Date:  2018-11-17       Impact factor: 3.520

6.  Alda-1 Protects Against Acrolein-Induced Acute Lung Injury and Endothelial Barrier Dysfunction.

Authors:  Qing Lu; Miles Mundy; Eboni Chambers; Thilo Lange; Julie Newton; Diana Borgas; Hongwei Yao; Gaurav Choudhary; Rajshekhar Basak; Mahogany Oldham; Sharon Rounds
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

7.  Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.

Authors:  Aneta Stachowicz; Rafał Olszanecki; Maciej Suski; Anna Wiśniewska; Justyna Totoń-Żurańska; Józef Madej; Jacek Jawień; Magdalena Białas; Krzysztof Okoń; Mariusz Gajda; Katarzyna Głombik; Agnieszka Basta-Kaim; Ryszard Korbut
Journal:  J Am Heart Assoc       Date:  2014-11-12       Impact factor: 5.501

8.  Decreased autophagy: a major factor for cardiomyocyte death induced by β1-adrenoceptor autoantibodies.

Authors:  L Wang; H Hao; J Wang; X Wang; S Zhang; Y Du; T Lv; L Zuo; Y Li; H Liu
Journal:  Cell Death Dis       Date:  2015-08-27       Impact factor: 8.469

9.  The Determining Role of Mitochondrial Reactive Oxygen Species Generation and Monoamine Oxidase Activity in Doxorubicin-Induced Cardiotoxicity.

Authors:  Salvatore Antonucci; Moises Di Sante; Federica Tonolo; Laura Pontarollo; Valeria Scalcon; Petra Alanova; Roberta Menabò; Andrea Carpi; Alberto Bindoli; Maria Pia Rigobello; Marco Giorgio; Nina Kaludercic; Fabio Di Lisa
Journal:  Antioxid Redox Signal       Date:  2020-07-07       Impact factor: 8.401

Review 10.  The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.

Authors:  Hong Zhang; Liwu Fu
Journal:  Acta Pharm Sin B       Date:  2021-02-11       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.